Salio M - Search Results

1

Biology of CD1- and MR1-restricted T cells.

Salio M, Silk JD, Jones EY, Cerundolo V. Salio M, et al. Annu Rev Immunol. 2014;32:323-66. doi: 10.1146/annurev-immunol-032713-120243. Epub 2014 Jan 31. Annu Rev Immunol. 2014. PMID: 24499274 Review.

2

Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells.

Salio M, Cerundolo V, Lanzavecchia A. Salio M, et al. Eur J Immunol. 2000 Feb;30(2):705-8. doi: 10.1002/1521-4141(200002)30:2<705::AID-IMMU705>3.0.CO;2-P. Eur J Immunol. 2000. PMID: 10671230 Free article.

3

A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response.

Dunbar PR, Smith CL, Chao D, Salio M, Shepherd D, Mirza F, Lipp M, Lanzavecchia A, Sallusto F, Evans A, Russell-Jones R, Harris AL, Cerundolo V. Dunbar PR, et al. Among authors: salio m. J Immunol. 2000 Dec 1;165(11):6644-52. doi: 10.4049/jimmunol.165.11.6644. J Immunol. 2000. PMID: 11086110

4

Mature dendritic cells prime functionally superior melan-A-specific CD8+ lymphocytes as compared with nonprofessional APC.

Salio M, Shepherd D, Dunbar PR, Palmowski M, Murphy K, Wu L, Cerundolo V. Salio M, et al. J Immunol. 2001 Aug 1;167(3):1188-97. doi: 10.4049/jimmunol.167.3.1188. J Immunol. 2001. PMID: 11466333

5

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.

Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, Ogg GS, King A, Lechner F, Spina CA, Little S, Havlir DV, Richman DD, Gruener N, Pape G, Waters A, Easterbrook P, Salio M, Cerundolo V, McMichael AJ, Rowland-Jones SL. Appay V, et al. Among authors: salio m. Nat Med. 2002 Apr;8(4):379-85. doi: 10.1038/nm0402-379. Nat Med. 2002. PMID: 11927944

6

Competition between CTL narrows the immune response induced by prime-boost vaccination protocols.

Palmowski MJ, Choi EM, Hermans IF, Gilbert SC, Chen JL, Gileadi U, Salio M, Van Pel A, Man S, Bonin E, Liljestrom P, Dunbar PR, Cerundolo V. Palmowski MJ, et al. Among authors: salio m. J Immunol. 2002 May 1;168(9):4391-8. doi: 10.4049/jimmunol.168.9.4391. J Immunol. 2002. PMID: 11970981

7

Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes.

Gadola SD, Dulphy N, Salio M, Cerundolo V. Gadola SD, et al. Among authors: salio m. J Immunol. 2002 Jun 1;168(11):5514-20. doi: 10.4049/jimmunol.168.11.5514. J Immunol. 2002. PMID: 12023346

8

Immunotherapy of colorectal cancer.

Smith CL, Dulphy N, Salio M, Cerundolo V. Smith CL, et al. Among authors: salio m. Br Med Bull. 2002;64:181-200. doi: 10.1093/bmb/64.1.181. Br Med Bull. 2002. PMID: 12421733 Review.

9

The use of HLA class I tetramers to design a vaccination strategy for melanoma patients.

Palmowski M, Salio M, Dunbar RP, Cerundolo V. Palmowski M, et al. Among authors: salio m. Immunol Rev. 2002 Oct;188:155-63. doi: 10.1034/j.1600-065x.2002.18814.x. Immunol Rev. 2002. PMID: 12445289 Review.

10

Plasmacytoid dendritic cells prime IFN-gamma-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions.

Salio M, Cella M, Vermi W, Facchetti F, Palmowski MJ, Smith CL, Shepherd D, Colonna M, Cerundolo V. Salio M, et al. Eur J Immunol. 2003 Apr;33(4):1052-62. doi: 10.1002/eji.200323676. Eur J Immunol. 2003. PMID: 12672071 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

172 results

Search Page